Proliferate and survive: Cell division cycle and apoptosis in human neuroblastoma

Haematologica

Volumn 87, Issue 2, 2002, Pages 196-214

  Borriello, Adriana ^a   Roberto, Roberta ^a   Della Ragione, Fulvio ^a   Iolascon, Achille ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Apoptosis; Caspase 8; Cell division cycle; Id2; Neuroblastoma; Survivin

Indexed keywords

CASPASE 8; RETINOBLASTOMA PROTEIN; SURVIVIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELL SURVIVAL; CHILDHOOD CANCER; GENE AMPLIFICATION; GENE INACTIVATION; GENE OVEREXPRESSION; HUMAN; NEUROBLASTOMA; ONCOGENE C MYB;

ANIMALS; APOPTOSIS; CASPASE 8; CASPASE 9; CASPASES; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CELL SURVIVAL; CHILD; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; HUMANS; INFANT; INHIBITOR OF DIFFERENTIATION PROTEIN 2; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; REMISSION, SPONTANEOUS; REPRESSOR PROTEINS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036180313     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (176)

1. Infant cancer in the U.S.: Histology-specific incidence and trends, 1973 to 1992
2. The National Cancer Data Base report on patterns of childhood cancers in the United States
3. Mutation and cancer: Neuroblastoma and pheochromocytoma
4. Molecular biology of neuroblastoma
5. Special pattern of widespread neuroblastoma with a favourable prognosis
6. Principles of CDK regulation
7. Cyclin-dependent protein kinases: Key regulators of the eukaryotic cell cycle
8. G1 phase progression: Cycling on cue
9. Control of the G1/S transition
10. Mammalian G1 cyclins
11. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth
12. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF
13. Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1
14. The role of cyclin E in cell proliferation, development and cancer
15. D-type cyclin-dependent kinase activity in mammalian cells
16. Interaction between Cdc37 and Cdk4 in human cells
17. Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp90 that binds and stabilizes Cdk4
18. CDK inhibitors: Positive and negative regulators of G1-phase progression
19. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts
20. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase
21. Ectopic expression of Cdc25A accelerates the G(1)/S transition and leads to premature activation of cyclin E- and cyclin A-dependent kinases
22. Rapid destruction of human Cdc25A in response to DNA damage
23. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-β in cells lacking the CDK inhibitor p15
24. Cell cycle start from quiescence controlled by tyrosine phosphorylation of Cdk4
25. Cell-cycle inhibitors: Three families united by a common cause
26. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex
27. Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27(Kip1) with cyclin A-cdk2 and cyclin D2-cdk4
28. INK4a
29. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d
30. WAF1, a potential mediator of p53 tumor suppression
31. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
32. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
33. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
34. Radiation-induced cell cycle arrest compromised by p21 deficiency
35. p53-dependent elevation of p21waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadate-sensitive regulatory system
36. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage
37. Cip1 in muscle and other terminally differentiating cells
38. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status
39. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells
40. NK4a and other loci
41. Kip1 accumulation during the cell cycle
42. Kip1) mRNA is a mechanism contributing to accumulation during growth arrest
43. Kip1 gene promoter
44. Kip1) gene promoter that lacks vitamin D response elements
45. Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and post-transcriptional mechanisms
46. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
47. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
48. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
49. Kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on Cdk2 activity and the proteasome
50. Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): Evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway
51. Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
52. New functional activities for the p21 family of CDK inhibitors
53. α interferon suppresses the cyclin D3 and cdc25A genes, leading to a reversible GO-like arrest
54. INK4a)
55. Apoptosis
56. Apoptosis
57. The control of apoptosis in mammalian cells
58. Apoptosis
59. Cell suicide for beginners
60. Apoptosis and disease
61. Apoptosis in the pathogenesis and treatment of disease
62. Apoptosis and disease: Regulation and clinical relevance of programmed cell death
63. Signaling by p53: Breaking the MDM2-p53 circuit
64. Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling
65. Bcl-2: An antidote to programmed cell death
66. The Bcl-2 family of proteins and activation of ICE-CED-3 family of proteases: A balancing act in apoptosis?
67. Bcl-2 family proteins
68. Mitochondria and apoptosis
69. Mitochondrial control of apoptosis
70. Cytochrome C: Can't live with it; can't live without it
71. Mammalian cell death proteases: A family of highly conserved aspartate specific cysteine proteases
72. Caspases: The proteases of the apoptotic pathway
73. Caspases: Intracellular signaling by proteolysis
74. Caspases: Enemies within
75. The inhibitors of apoptosis (IAPs) and their emerging role in cancer
76. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
77. Fas and Fas ligand: A death factor and its receptor
78. The Fas death factor
79. Clinical, immunological, and pathological consequences of Fas-deficient conditions
80. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
81. Lethal effect of the anti-Fas antibody in mice
82. Apoptosis control by death and decoy receptors
83. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
84. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
85. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
86. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling
87. Identification and characterisation of a new member of the TNF family that induces apoptosis
88. p75 mediated apoptosis in neuroblastoma cells is inhibited by expression of TrkA
89. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
90. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas
91. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
92. Kip1 in gastric cancer
93. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
94. kip1) expression in rectal cancer correlates with disease-free survival
95. KIP1 are associated with survival in patients treated by salvage prostatectomy after radiation therapy
96. Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma
97. p16(MTS-1/CDKN2/INK4a) in cancer progression
98. The Pezcoller lecture: Cancer cell cycles revisited
99. Cell division cycle alterations and human tumors
100. Molecular aspects of multiple myeloma
101. Melanoma genetics: An update with focus on the CDKN2A (p16)/ARF tumor suppressors
102. The genetics of cutaneous melanoma
103. The p16 and p18 tumor suppressor genes in neuroblastoma: Implications for drug resistance
104. N2C) in neuroblastoma
105. No CDKN2 mutations in neuroblastomas
106. Loss of heterozygosity at chromosome 9p21 in primary neuroblastomas: Evidence for two deleted regions
107. N2A) gene alterations in neuroblastoma
108. A cell cycle regulator potentially involved in genesis of many tumor types
109. Kip1) genes in neuroblastomas
110. Mutational analysis of the p16 gene in human neuroblastomas
111. ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma
112. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma
113. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage
114. Amplification of N-myc sequences in primary human neuroblastomas: Correlation with advanced disease stage
115. Age-dependent prognostic significance of N-myc amplification in neuroblastoma. The Italian experience
116. Targeted expression of MYCN causes neuroblastoma in transgenic mice
117. Id helix-loop-helix proteins in cell growth and differentiation
118. The helix-loop-helix protein Id-2 enhances cell proliferation and binds to retinoblastoma protein
119. Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins
120. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
121. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells
122. Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer
123. Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: Evidence of a decreased proteasome-dependent degradation
124. Kip1) genes in neuroblastomas
125. KIP1 and c-Jun coactivator JAB1 in neuroblastoma
126. KIP1) is prognostic and independent of MYCN amplification in human neuroblastoma
127. Allelic loss and neuroblastoma suppressor genes
128. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma
129. Identification of two distinct chromosome 12-derived amplification units in neuroblastoma cell line NGP
130. Molecular cytogenetic characterization and physical mapping of 12q13-15 amplification in human cancers
131. Cytoplasmic sequestration of wild-type p53 protein impairs the G1 checkpoint after DNA damage
132. Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines
133. The p53/p63/p73 family of transcription factors: Overlapping and distinct functions
134. From p63 to p53 across p73
135. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers
136. Methylation-independent silencing of the p73 gene in neuroblastoma
137. Induction of apoptosis by p75 neurotrophin receptor in human neuroblastoma cells
138. Regulation of NGF responsiveness in human neuroblastoma
139. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells
140. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells
141. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis
142. Differential expression of Bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin
143. Cellular death in neuroblastoma: In situ correlation of apoptosis and bcl-2 expression
144. Expression of bcl-2 gene product in neuroblastoma
145. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification
146. Relationship between bcl-2 and myc gene expression in human neuroblastoma
147. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma
148. In situ detection of DNA fragmentation and expression of bcl-2 in human neuroblastoma: Relation to apoptosis and spontaneous regression
149. Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma
150. Evidence of apoptosis in neuroblastoma at onset and relapse. An analysis of a large series of tumors
151. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma
152. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
153. Control of apoptosis and mitotic spindle checkpoint by survivin
154. Regulation of apoptosis at cell division by p34 cdc2 phosphorylation of survivin
155. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7
156. Survivin does not inhibit caspase-3 activity
157. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
158. Quick quantitative analysis of gene dosages associated with prognosis in neuroblastoma
159. Cell death inhibition: Keeping caspases in check
160. Baculoviruses and apoptosis: The good, the bad, and the ugly
161. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
162. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-induced apoptosis
163. Resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression
164. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53
165. Neurotrophin receptors, tumor progression and tumor maturation
166. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells
167. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma
168. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants
169. Expression of TrkC in favorable human neuroblastomas
170. Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: A study of 1,150 tumors and fetal and adult normal tissues
171. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
172. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia
173. ink4b gene deletions in childhood acute lymphoblastic leukemia
174. Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions
175. High frequency of homozygous deletions of CDK4I gene in childhood acute lymphoblastic leukemia
176. Homozygous deletion of the p16/MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome